ARCHIVES

ELM’s CHOP-DS Aims For 15% Of Patients

This article is from The Cancer Letter archive.

Vol. 11 No. 35 | September 13, 1985

Download PDF Visit The Full Archive

Related Articles

Moertel Criticizes Janssen Over Levamisole Price, Delivers Final Report On Intergroup Adjuvant Trial

June 12, 1992

In Brief: House Appropriations Subcommitee Plans Hearing On NCI March 24; New DTP Director Sought

February 25, 1983

Professional Societies: FASEB Urges Increase Of 15% For NIH, Double In Five Years

March 6, 1998

Decision Delayed On Breast Cancer Study Until After Consensus Meeting

July 5, 1985

Onco TCS Induces Responses In Relapsed Aggressive NHL

February 28, 2003

Cancer Rates May Rise 50% By 2020, IARC Says

April 18, 2003